Clinical trial
A randomized, double-blind, double-dummy, placebo-controlled, 3-period crossover study to evaluate the pharmacodynamics, pharmacokinetics, safety and tolerability of orally inhaled indacaterol administered via the EPIC test fixture and the Concept1 device
To assess the bronchodilator effect of once-daily lactose-blended (LB) indacaterol administered via the EPIC test fixture and Concept1 in adult patients with persistent asthma compared with placebo as measured by trough FEV1 after 3 days of treatment.
| Category | Value |
|---|---|
| Study start date | 2013-04-11 |